| Literature DB >> 28817551 |
Maureen Martinez, Hemant Shukla, Joanna Nikulin, Mufti Zubair Wadood, Stephen Hadler, Chukwuma Mbaeyi, Rudolph Tangermann, Jaume Jorba, Derek Ehrhardt.
Abstract
Afghanistan, Pakistan, and Nigeria remain the only countries where the transmission of endemic wild poliovirus type 1 (WPV1) continues (1). This report describes polio eradication activities, progress, and challenges in Afghanistan during January 2016-June 2017 and updates previous reports (2,3). Thirteen WPV1 cases were confirmed in Afghanistan in 2016, a decrease of seven from the 20 cases reported in 2015. From January to June 2017, five WPV1 cases were reported, compared with six during the same period in 2016. The number of affected districts declined from 23 (including WPV1-positive acute flaccid paralysis [AFP] cases and positive environmental sewage samples) in 2015 to six in 2016. To achieve WPV1 eradication, it is important that Afghanistan's polio program continue to collaborate with that of neighboring Pakistan to track and vaccinate groups of high-risk mobile populations and strengthen efforts to reach children in security-compromised areas.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28817551 PMCID: PMC5657670 DOI: 10.15585/mmwr.mm6632a5
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Acute flaccid paralysis (AFP) surveillance indicators and reported cases of wild poliovirus (WPV), by region and period — Afghanistan, January 2016–June 2017*
| Region of Afghanistan | AFP surveillance indicators (2016) | No. WPV cases reported | ||||
|---|---|---|---|---|---|---|
| No. AFP cases | Rate of nonpolio AFP† | % of AFP cases with adequate specimens§ | January–June 2016 | July–December 2016 | January–June 2017 | |
|
|
|
|
|
|
|
|
| Badakhshan | 56 | 9.8 | 98.2 | 0 | 0 | 0 |
| Northeastern | 285 | 12.6 | 92.2 | 0 | 0 | 1 |
| Northern | 319 | 12.7 | 90.9 | 0 | 0 | 0 |
| Central | 507 | 11 | 96.4 | 0 | 0 | 0 |
| Eastern | 405 | 20.4 | 95.4 | 4 | 0 | 0 |
| Southeastern | 261 | 13.2 | 91.4 | 0 | 7 | 0 |
| Southern | 588 | 16.7 | 85.2 | 2 | 0 | 4 |
| Western | 470 | 17.6 | 94.0 | 0 | 0 | 0 |
* Data current through June 30, 2017.
† Per 100,000 children aged <15 years. Surveillance target is 2/100,000 children aged <15 years.
§ Surveillance target is that at least 80% of AFP cases have “adequate” stool specimens collected. “Adequate” stool specimens are defined as two stool specimens of sufficient quality for laboratory analysis, collected ≥24 hours apart, both within 14 days of paralysis onset, and arriving to a World Health Organization–accredited laboratory by reverse cold chain and with proper documentation.
FIGURE 1Number of cases of wild poliovirus type 1 (WPV1) and circulating vaccine-derived poliovirus type 2 (cVDPV2), by month and year of paralysis onset — Afghanistan, 2013–2017
FIGURE 2Cases of wild poliovirus type 1 (WPV1), by province — Afghanistan, January 2016–June 2017*
* Each dot represents one case. Dots are randomly placed within provinces.